PAREQ AG

PAREQ AG is rated 3 out of 5 in the category biotechnology. Read and write reviews about PAREQ AG. PAREQ - STRIVING FOR OPTIMIZED THERAPIES We identify predictive biomarkers through analyzing the systematics of a disease. By utilizing our novel, Artificial Intelligence-based platform (PAREQ, powered by Qlaym), PAREQ aims to advance personalized medicine. Working with our partners, we identify predictive markers to streamline the development, positioning and lifetime management of new drugs. Our platform links drug efficacy to measurable predictors and can identify or enrich the critical responder populations. Through identifying the shared systematics of different diseases, we can also strive for additional indications.